DOH Logo linking to the DOH Home Page

Newborn Screening Header


You are here: DOH Home  » EHSPHL Home » PHL Home » NBS Home »Homocystinuria General Overview Page Search | Employees
 Site Directory:    Homocystinuria General Overview Page

Disorders

Health Professionals' Page

Parents' Page

• Reports & Publications

Related Links

NBS News

NBS Privacy Policy

Statistics

Contact NBS

 

 

Access Washington Logo linking to Access Washington Home Page

 

 

 

 

What should I know about Homocystinuria?

Below are some frequently asked questions.  If the information contained on this page does not answer all of your questions or you would just simply like more information, please check out the Clinical Description & Related Links pages or contact us with your specific question.

(click here for printer friendly version of this information in pdf format)

Please see the viewer page for free software to enable viewing of pdf files.



Q. What is Homocystinuria?
A. Homocystinuria is a treatable disorder that affects the way the body processes protein.  Children with homocystinuria cannot use a part of the protein called methionine.  If left untreated, methionine and related molecules build up in the bloodstream and lead to brain damage and other disabilities.

Q. Is there only one form of homocystinuria?
A. No, there are several forms of homocystinuria.  Some people with homocystinuria are treated slightly differently than others because they respond to treatment with a specific vitamin.

Q. How does the body normally process methionine?
A. The body normally converts methionine into a different form called cysteine, which is then used by the body in other metabolic functions. 

Q. What happens to methionine in a child with homocystinuria?
A. In a child with homocystinuria, methionine cannot be converted to cysteine because one of the needed enzymes does not work properly.  This results in large amounts of methionine and related molecules, which are toxic to the brain and nervous system.

Q. What are the effects of having homocystinuria if it is not treated?
A. Without treatment, about half of people with homocystinuria die, usually from blood clots that block normal blood flow.  Untreated homocystinuria can result in mental retardation and other problems of the nervous system.  It can also result in eye problems and skeletal abnormalities. 

Q. What is the treatment for homocystinuria?
A. Some people with homocystinuria respond to vitamin B6 (pyridoxine).  Those who do not respond to this treatment are placed on a special diet that is low in methionine.  To prevent mental retardation and developmental disability, treatment must begin shortly after birth.  People with homocystinuria require specialized treatment through a clinic with experience in treating this disorder. 

Q. Why would a child have homocystinuria?
A. Homocystinuria is an inherited disorder.  It results when a baby receives a double-dose of a specific non-working gene involved in methionine conversion (one from each parent).  For more information about this, contact your health care provider or a genetic counselor.

Q. How common is homocystinuria?
About one in every 200,000 babies in the United States is born with homocystinuria.


Documents posted in .pdf version on the Department of Health Web site will be made available in an alternative format on request to users who are unable to download or view .pdf files on the Web. To request an alternative format, contact: Gary Resler.

DOH Home | Access Washington | Privacy Notice | Disclaimer/Copyright Information

Washington State Department of Health
Newborn Screening Program
1610 NE 150th Street NE
Shoreline, Washington, 98155

Last Update : 11/20/2006 10:59 AM
Send inquires about DOH and its programs to the Health Consumer Assistance Office
Comments or questions regarding this web site? Send mail to Gary Resler.